Anthony C. Hooper joined Amgen in October 2011 as executive vice president of Global Commercial Operations, a role he held until August 2018. During his tenure, Hooper led the transformation of Amgen's commercial organization, placing a relentless focus on putting patients at the center of all the company’s activities. Under his leadership, Amgen grew sales by nearly 50 percent, launched six new first-in-class medicines for serious diseases, expanded into 50 new countries, and established a new biosimilars business.
Prior to joining Amgen, Hooper spent more than 15 years at Bristol-Myers Squibb. His last role there was senior vice president, Global Commercial Operations and president of the company’s $15 billion pharmaceutical business in the Americas, Japan and Intercontinental regions. Previously, Hooper was assistant vice president of Global Marketing for Wyeth Laboratories and led the international marketing group for Lederle International.
Hooper earned law and MBA degrees from the University of South Africa.